New Zealand - Re-Export of Ambergris, Civet, Musk for Pharmaceutical Use
At $31,784.62 in 2017, the country was ranked number 4 comparing other countries in Re-Export of Ambergris, Civet, Musk for Pharmaceutical Use. New Zealand is overtaken by United Arab Emirates, which was number 3 with $36,204.92 and is followed by Namibia with $101.78. United States lead the ranking with $239,823 in 2019, a growth of 6.6% compared to 2018.
Loading...
| Date | US Dollars |
|---|---|
| 2017 | 31,784.62 |
| 2016 | |
| 2015 | 16,685.32 |
| 2014 | |
| 2013 |
Download all data from 2005 to 2017
How does New Zealand rank in Re-Export of Ambergris, Civet, Musk for Pharmaceutical Use?
| # | 5 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
239,823.00 | 2019 | +6.5 % | +10.7 % | View data |
| 2 |
#2
Saudi Arabia
|
45,072.09 | 2016 | NA | NA | View data |
| 3 |
#3
United Arab Emirates
|
36,204.92 | 2019 | -26.3 % | +22.8 % | View data |
| 4 |
#4
New Zealand
|
31,784.62 | 2017 | NA | NA | View data |
| 5 |
#5
Namibia
|
101.78 | 2019 | -15.3 % | NA | View data |